The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy
Open accessAbstract
Diabetic retinopathy, characterized as a microangiopathy and neurodegenerative disease, is the leading cause of visual impairment in diabetic patients. Many clinical features observed in diabetic retinopathy, such as capillary occlusion, acellular capillaries and retinal non-perfusion, aggregate retinal ischemia and represent relatively late events in diabetic retinopathy. In fact, retinal microvascular injury is an early event in diabetic retinopathy involving multiple biochemical alterations, and is manifested by changes to the retinal neurovascular unit and its cellular components. Currently, intravitreal anti-vascular endothelial growth factor therapy is the first-line treatment for diabetic macular edema, and benefits the patient by decreasing the edema and improving visual acuity. However, a significant proportion of patients respond poorly to anti-vascular endothelial growth factor treatments, indicating that factors other than vascular endothelial growth factor are involved in the pathogenesis of diabetic macular edema. Accumulating evidence confirms that low-grade inflammation plays a critical role in the pathogenesis and development of diabetic retinopathy as multiple inflammatory factors, such as interleukin-1β, monocyte chemotactic protein-1 and tumor necrosis factor -α, are increased in the vitreous and retina of diabetic retinopathy patients. These inflammatory factors, together with growth factors such as vascular endothelial growth factor, contribute to blood-retinal barrier breakdown, vascular damage and neuroinflammation, as well as pathological angiogenesis in diabetic retinopathy, complicated by diabetic macular edema and proliferative diabetic retinopathy. In addition, retinal cell types including microglia, Müller glia, astrocytes, retinal pigment epithelial cells, and others are activated, to secrete inflammatory mediators, aggravating cell apoptosis and subsequent vascular leakage. New therapies, targeting these inflammatory molecules or related signaling pathways, have the potential to inhibit retinal inflammation and prevent diabetic retinopathy progression. Here, we review the relevant literature to date, summarize the inflammatory mechanisms underlying the pathogenesis of diabetic retinopathy, and propose inflammation-based treatments for diabetic retinopathy and diabetic macular edema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedDifferential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Diabetic Retinopathy: Pathophysiology and Treatments
Wang, W., & Lo, A. C. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061816 · Cited by 1,358
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Role of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750 · cited 5×
“…et al., 2018), as pro-inflammatory mediators, adhesion molecules, chemokines, and growth factors (Altmann and Schmidt, 2018; Lu et al., 2018; Rübsam et al., 2018; Wang and Lo, 2018; Whitehead et al., 2018), are increased and extensively involved in the pathogenesis of DR. Inflammatory cells…”
BackgroundInfluentialCampochiaro, P. A., Brown, D. M., Pearson, A., Chen, S., Boyer, D., Ruiz-Moreno, J., Garretson, B., Gupta, A., Hariprasad, S. M., Bailey, C., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.030 · Cited by 517
GILLIES, M., SUTTER, F., SIMPSON, J., LARSSON, J., ALI, H., & ZHU, M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.065 · Cited by 425
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Microglial Activation in Human Diabetic Retinopathy
Zeng, H.-Y. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.65 · Cited by 402
Altmann, C., & Schmidt, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 402
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
Wang, J., Xu, X., Elliott, M. H., Zhu, M., & Le, Y.-Z. (2010) · Diabetes · doi:10.2337/db09-1420 · Cited by 396
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
Müller cells and diabetic retinopathy
Coughlin, B. A., Feenstra, D. J., & Mohr, S. (2017) · Vision Research · doi:10.1016/j.visres.2017.03.013 · Cited by 332
Microglia and Inflammatory Responses in Diabetic Retinopathy
Kinuthia, U. M., Wolf, A., & Langmann, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.564077 · Cited by 321
Vincent, J. A., & Mohr, S. (2007) · Diabetes · doi:10.2337/db06-0427 · Cited by 298
Doganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Recent Advances in Ophthalmic Drug Delivery
Kompella, U. B., Kadam, R. S., & Lee, V. H. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.40 · Cited by 285
Sahni, J., Patel, S. S., Dugel, P. U., Khanani, A. M., Jhaveri, C. D., Wykoff, C. C., Hershberger, V. S., Pauly-Evers, M., Sadikhov, S., Szczesny, P., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.03.023 · Cited by 285
Zur, D., Iglicki, M., Busch, C., Invernizzi, A., Mariussi, M., Loewenstein, A., Busch, C., Cebeci, Z., Chhablani, J. K., Chaikitmongkol, V., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.08.031 · Cited by 271
Joussen, A. M., Doehmen, S., Le, M. L., Koizumi, K., Radetzky, S., Krohne, T. U., Poulaki, V., Semkova, I., & Kociok, N. (2009) · PubMed Central · Cited by 263
Zhang, S. X., Wang, J. J., Gao, G., Parke, K., & Ma, J.-X. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02008 · Cited by 262
Coscas, G., De Benedetto, U., Coscas, F., Li Calzi, C. I., Vismara, S., Roudot-Thoraval, F., Bandello, F., & Souied, E. (2013) · Ophthalmologica · doi:10.1159/000342159 · Cited by 235
Pavlou, S., Lindsay, J., Ingram, R., Xu, H., & Chen, M. (2018) · BMC Immunology · doi:10.1186/s12865-018-0261-0 · Cited by 235
Effects of Diabetes on the Eye
Lutty, G. A. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12979 · Cited by 233
Diabetic retinopathy and inflammation: Novel therapeutic targets
Das, A., Rangasamy, S., & McGuire, P. (2012) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.92116 · Cited by 228
Retinal microglia initiate neuroinflammation in ocular autoimmunity
Okunuki, Y., Mukai, R., Nakao, T., Tabor, S. J., Butovsky, O., Dana, R., Ksander, B. R., & Connor, K. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820387116 · Cited by 216
Huang, H., Gandhi, J. K., Zhong, X., Wei, Y., Gong, J., Duh, E. J., & Vinores, S. A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5768 · Cited by 215
Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
Semeraro, F., Morescalchi, F., Cancarini, A., Russo, A., Rezzola, S., & Costagliola, C. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.04.002 · Cited by 205
The RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
Boss, J. D., Singh, P. K., Pandya, H. K., Tosi, J., Kim, C., Tewari, A., Juzych, M. S., Abrams, G. W., & Kumar, A. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21973 · Cited by 200
Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
Whitehead, M., Wickremasinghe, S., Osborne, A., Van Wijngaarden, P., & Martin, K. R. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1545836 · Cited by 198
Vascular Wall Progenitor Cells in Health and Disease
Psaltis, P. J., & Simari, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.305368 · Cited by 195
Ibrahim, A. S., El-Remessy, A. B., Matragoon, S., Zhang, W., Patel, Y., Khan, S., Al-Gayyar, M. M., El-Shishtawy, M. M., & Liou, G. I. (2011) · Diabetes · doi:10.2337/db10-1160 · Cited by 190
MURUGESWARI, P., SHUKLA, D., RAJENDRAN, A., KIM, R., NAMPERUMALSAMY, P., & MUTHUKKARUPPAN, V. (2008) · Retina · doi:10.1097/iae.0b013e31816576d5 · Cited by 189
Torres-Castro, I., Arroyo-Camarena, Ú. D., Martínez-Reyes, C. P., Gómez-Arauz, A. Y., Dueñas-Andrade, Y., Hernández-Ruiz, J., Béjar, Y. L., Zaga-Clavellina, V., Morales-Montor, J., Terrazas, L. I., et al. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.001 · Cited by 172
Hu, H., He, J., Johnson, D., Wei, Y., Liu, Y., Wang, S., Lutty, G. A., Duh, E. J., Carmeliet, P., & Semba, R. D. (2014) · Diabetes · doi:10.2337/db14-0016 · Cited by 169
Brown, D. M., Emanuelli, A., Bandello, F., Barranco, J. J. E., Figueira, J., Souied, E., Wolf, S., Gupta, V., Ngah, N. F., Liew, G., et al. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.01.004 · Cited by 169
Sorrentino, F. S., Allkabes, M., Salsini, G., Bonifazzi, C., & Perri, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.001 · Cited by 166
Leukocytes in Diabetic Retinopathy
Chibber, R., Ben-Mahmud, B., Chibber, S., & Kohner, E. (2007) · Current Diabetes Reviews · doi:10.2174/157339907779802139 · Cited by 162
Diabetic retinopathy and dysregulated innate immunity
Xu, H., & Chen, M. (2017) · Vision Research · doi:10.1016/j.visres.2017.04.013 · Cited by 152
Anti-Inflammatory Therapy for Diabetic Retinopathy
Zhang, W., Liu, H., Rojas, M., Caldwell, R. W., & Caldwell, R. B. (2011) · Immunotherapy · doi:10.2217/imt.11.24 · Cited by 146
Behl, Y., Krothapalli, P., Desta, T., Roy, S., & Graves, D. T. (2009) · Diabetes · doi:10.2337/db08-0537 · Cited by 140
Brown, D. M., Emanuelli, A., Bandello, F. M., Escobar-Barranco, J. J., Figueira, J., Souied, E. H., Wolf, S., Gupta, V., Ngah, N. F., Liew, G., et al. (2022) · doi:10.48350/181493 · Cited by 140
Carpi-Santos, R., Reis, R. A. D. M., Gomes, F. C. A., & Calaza, K. D. C. (2022) · Antioxidants · doi:10.3390/antiox11040617 · Cited by 138
Portillo, J. C., Corcino, Y. L., Miao, Y., Tang, J., Sheibani, N., Kern, T. S., Dubyak, G., & Subauste, C. S. (2016) · Diabetes · doi:10.2337/db16-0051 · Cited by 130
Biodegradable Intraocular Therapies for Retinal Disorders: Progress to Date
Kuno, N., & Fujii, S. (2010) · Drugs & Aging · doi:10.2165/11530970-000000000-00000 · Cited by 127
Campochiaro, P. A., Khanani, A. M., Singer, M. A., Patel, S. S., Boyer, D. S., Dugel, P. U., Kherani, S., Withers, B., Gambino, L., Peters, K. G., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.04.025 · Cited by 121
Pericytes, inflammation, and diabetic retinopathy
Spencer, B. G., Estevez, J. J., Liu, E., Craig, J. E., & Finnie, J. W. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00647-9 · Cited by 119
Retinal pigment epithelium-secretome: A diabetic retinopathy perspective
Murugeswari, P., Subramani, M., Jayadev, C., Shetty, R., & Das, D. (2017) · Cytokine · doi:10.1016/j.cyto.2017.02.013 · Cited by 118
Astrocytic and microglial response in experimentally induced diabetic rat brain
Nagayach, A., Patro, N., & Patro, I. K. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9562-z · Cited by 117
Regression of neovascular age-related macular degeneration following infliximab therapy
Markomichelakis, N. N., THEODOSSIADIS, P. G., & Sfikakis, P. P. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.09.058 · Cited by 115
Maier, R., Weger, M., Haller–Schober, E.-M., El‐Shabrawi, Y., Wedrich, A., Theisl, A., Aigner, R., Barth, A., & Haas, A. (2008) · PubMed Central · Cited by 114
Markham, A. (2019) · Drugs · doi:10.1007/s40265-019-01231-9 · Cited by 114
Scholz, R., Caramoy, A., Bhuckory, M. B., Rashid, K., Chen, M., Xu, H., Grimm, C., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0422-5 · Cited by 111 · cited 1×
“However, sustained hyperglycemia and harmful insults induce the overproduction of pro-inflammatory factors from microglia, such as TNF-α, IL-1β, and iNOS (Scholz et al., 2015), resulting in phagocytosis, neuronal death, and BRB breakdown.”
BackgroundXie, H., Zhang, C., Liu, D., Yang, Q., Tang, L., Wang, T., Tian, H., Lü, L., Xu, J., Gao, F., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05299-x · Cited by 107
Self-citationTang, L., Zhang, C., Lü, L., Tian, H., Liu, K., Luo, D., Qiu, Q., Xu, G., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831660 · Cited by 102
Self-citationMadonna, R., Giovannelli, G., Confalone, P., Renna, F. V., Geng, Y., & Caterina, R. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0342-4 · Cited by 93
Hove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 81
Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography
Chung, Y.-R., Kim, Y. H., Ha, S. J., Byeon, H.-E., Cho, C., Kim, J. H., & Lee, K. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8164250 · Cited by 80
Stahel, M., Becker, M., Graf, N., & Michels, S. (2015) · Retina · doi:10.1097/iae.0000000000000701 · Cited by 68
High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway
Cheng, C., Chen, P., Lin, Y., & Kao, Y.-H. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.012 · Cited by 68
Al‐Rashed, F., Sindhu, S. T. A. K., Arefanian, H., Madhoun, A. S. A., Kochumon, S., Thomas, R., Al-Kandari, S., Alghaith, A., JACOB, T. K., Al‐Mulla, F., et al. (2020) · Cells · doi:10.3390/cells9081892 · Cited by 67
Shaw, L. T., Mackin, A. G., Shah, R., Jain, S., Jain, P., Nayak, R., & Hariprasad, S. M. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1763953 · Cited by 62
Intravitreal Steroids in Diabetic Macular Edema
Lattanzio, R., Cicinelli, M. V., & Bandello, F. M. (2017) · Developments in ophthalmology · doi:10.1159/000459691 · Cited by 61
Tang, L., Zhang, C., Yang, Q., Xie, H., Liu, D., Tian, H., Lu, L., Xu, J., Li, W., Xu, G., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30269 · Cited by 58 · cited 1×
“Our previous work demonstrated that melatonin maintained the inner BRB by up-regulating the expressions of tight junction proteins and decreasing the production of inflammatory factors such as ICAM-1, IL-1β, and TNF-α (Tang et al., 2021).”
BackgroundSelf-citationCurrent Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
Lü, L., Jiang, Y., Jaganathan, R., & Hao, Y. (2018) · Journal of Ophthalmology · doi:10.1155/2018/1694187 · Cited by 57
Therapeutic potential of curcumin in diabetic retinopathy (Review)
Yang, J., Miao, X., Yang, F., Cao, J., Liu, X., Fu, J., & Su, G. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4908 · Cited by 57
Captopril Inhibits Capillary Degeneration in the Early Stages of Diabetic Retinopathy
Zhang, J.-Z., Xia, X., Gao, L., & Kern, T. S. (2007) · Current Eye Research · doi:10.1080/02713680701584123 · Cited by 48
Self-citationTGF-β2 secretion from RPE decreases with polarization and becomes apically oriented
Hirsch, L., Nazari, H. K., Sreekumar, P. G., Kannan, R., Dustin, L., Zhu, D., Barrón, E., & Hinton, D. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.014 · Cited by 47
pEPito-driven PEDF Expression Ameliorates Diabetic Retinopathy Hallmarks
Calado, S. M., Diaz-Corrales, F. J. J., & Silva, G. A. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.169 · Cited by 30
HYPERREFLECTIVE FOCI AS A PATHOGENETIC BIOMARKER IN CHOROIDEREMIA
Romano, F., Arrigo, A., MacLaren, R. E., Issa, P. C., Birtel, J., Bandello, F. M., & Parodi, M. B. (2019) · Retina · doi:10.1097/iae.0000000000002645 · Cited by 28
Resolution of Inflammation in Retinal Disorders: Briefly the State
Trotta, M. C., Gesualdo, C., Petrillo, F., Lepre, C. C., Corte, A. D., Cavasso, G., Maggiore, G., Hermenean, A. O., Simonelli, F., D’Amico, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094501 · Cited by 27
C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus
Yang, X., Deng, Y. L., Gu, H., Lim, A., Snellingen, T., Liu, X.-P., Wang, N., Domalpally, A., Danis, R. P., & Liu, N. (2015) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.01.19 · Cited by 23
Anti-inflammatory effects of pelargonidin on TGFBIp-induced responses
Jeong, S., Ku, S., & Bae, J. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0322 · Cited by 21
Involvement of lncRNAs and Macrophages: Potential Regulatory Link to Angiogenesis
Jia, Y., & Zhou, Y. (2020) · Journal of Immunology Research · doi:10.1155/2020/1704631 · Cited by 20
Lefevere, E., Hove, I. V., Sergeys, J., STEEL, D. H., Schlingemann, R. O., Moons, L., & Klaassen, I. (2021) · Current Eye Research · doi:10.1080/02713683.2021.1966479 · Cited by 19
Spooner, K., Fraser‐Bell, S., Hong, T., & Chang, A. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13636 · Cited by 11
Metadata
- Authors
- Xu, G.-T., Zhang, J.-F., & Tang, L.
- Venue
- Neural Regeneration Research
- Publisher
- Medknow
- Published
- 2023
- Volume
- 18
- Issue
- 5
- Pages
- 976
- ISSN
- 1673-5374 (ISSN-L)
- OpenAlex
- W4306731659
- Cited by
- 280
- References
- 79
- FWCI
- 41.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.